Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98109, USA; email:
Annu Rev Immunol. 2020 Apr 26;38:705-725. doi: 10.1146/annurev-immunol-103019-085803.
The discovery of CD4 T cell subset-defining master transcription factors and framing of the Th1/Th2 paradigm ignited the CD4 T cell field. Advances in in vivo experimental systems, however, have revealed that more complex lineage-defining transcriptional networks direct CD4 T cell differentiation in the lymphoid organs and tissues. This review focuses on the layers of fate decisions that inform CD4 T cell differentiation in vivo. Cytokine production by antigen-presenting cells and other innate cells influences the CD4 T cell effector program [e.g., T helper type 1 (Th1), Th2, Th17]. Signals downstream of the T cell receptor influence whether individual clones bearing hallmarks of this effector program become T follicular helper cells, supporting development of B cells expressing specific antibody isotypes, or T effector cells, which activate microbicidal innate cells in tissues. These bifurcated, parallel axes allow CD4 T cells to augment their particular effector program and prevent disease.
CD4 T 细胞亚群限定性主转录因子的发现和 Th1/Th2 范例的提出激发了 CD4 T 细胞领域的研究。然而,体内实验系统的进展揭示了更复杂的谱系限定性转录网络在淋巴器官和组织中指导 CD4 T 细胞分化。本综述重点关注了体内 CD4 T 细胞分化所涉及的多个命运决定层次。抗原呈递细胞和其他固有细胞产生的细胞因子影响 CD4 T 细胞效应器程序[例如 T 辅助细胞 1(Th1)、Th2、Th17]。T 细胞受体下游的信号影响是否携带该效应器程序特征的单个克隆成为滤泡辅助 T 细胞,支持表达特定抗体同种型的 B 细胞的发育,或者成为 T 效应细胞,激活组织中的杀菌固有细胞。这些分叉的、平行的轴允许 CD4 T 细胞增强其特定的效应器程序并预防疾病。